Pathogenesis and prognosis of thrombotic microangiopathy

Clinical and Experimental Nephrology

Volumn 11, Issue 2, 2007, Pages 107-114

  Nangaku, Masaomi ^a   Nishi, Hiroshi ^a   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Hemolytic uremic syndrome (HUS); Thrombotic microangiopathy (TMA); Thrombotic thrombocytopenic purpura (TTP)

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; CYCLOSPORIN; FIBRINOGEN; TACROLIMUS; VEROTOXIN 1; VEROTOXIN 2; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ANTIBIOTIC THERAPY; COMPLEMENT ACTIVATION; DIARRHEA; DISEASE COURSE; ENDOCYTOSIS; ENDOTHELIAL DYSFUNCTION; ESCHERICHIA COLI; GENE MUTATION; GENETIC DISTANCE; GENETIC LINKAGE; GENETIC PREDISPOSITION; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MORTALITY; PATHOGENESIS; PATHOGENICITY; PLASMAPHERESIS; PROGNOSIS; PROTEIN SYNTHESIS; REVIEW; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; COMPLEMENT ACTIVATION; GENETIC PREDISPOSITION TO DISEASE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; PROGNOSIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; SHIGA TOXINS; THROMBOSIS;

EID: 34347323966     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-007-0466-7     Document Type: Review

References (91)

1. P Ruggenenti M Noris G Remuzzi 2001 Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura Kidney Int 60 831 46
2. HM Tsai 2003 Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura J Am Soc Nephrol 14 1072 81
3. JL Moake 2002 Thrombotic microangiopathies N Engl J Med 347 589 600
4. N Besbas D Karpman D Landau C Loirat W Proesmans G Remuzzi 2006 European Paediatric Research Group for HUS. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders Kidney Int 70 423 31
5. PI Tarr CA Gordon WL Chandler 2005 Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome Lancet 365 1073 86
6. M Nangaku SJ Shankland WG Couser RJ Johnson 1998 A new model of renal microvascular injury Curr Opin Nephrol Hypertens 7 457 62
7. LW Riley RS Remis SD Helgerson HB McGee JG Wells BR Davis 1983 Hemorrhagic colitis associated with a rare Escherichia coli serotype N Engl J Med 308 681 5
8. BP Bell M Goldoft PM Griffin MA Davis DC Gordon PI Tarr 1994 A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience JAMA 272 1349 53
9. I Tsuboi H Ida E Yoshikawa S Hiyoshi E Yamaji I Nakayama 1998 Antibiotic susceptibility of enterohemorrhagic Escherichia coli O157:H7 isolated from an outbreak in Japan in 1996 Antimicrobiol Agents Chemother 42 431 2
10. ME Fraser MM Chernaia YV Kozlov MN James 1994 Crystal structure of the holotoxin from Shigella dysenteriae at 2.5: a resolution Nat Struct Biol 1 59 64
11. B Boyd C Lingwood 1989 Verotoxin receptor glycolipid in human renal tissue Nephron 51 207 10
12. LA Robinson RM Hurley C Lingwood DG Matsell 1995 Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells Pediatr Nephrol 9 700 4
13. CA Lingwood 1994 Verotoxin-binding in human renal sections Nephron 66 21 8
14. T Takeda S Dohi T Igarashi T Yamanaka K Yoshiya N Kobayashi 1993 Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome J Infect 27 339 41
15. IM Pruimboom-Brees TW Morgan MR Ackermann ED Nystrom JE Samuel NA Cornick HW Moon 2000 Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins Proc Natl Acad Sci USA 97 10325 9
16. TG Obrig TP Moran JE Brown 1987 The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis Biochem J 244 287 94
17. C Zoja S Angioletti R Donadelli C Zanchi S Tomasoni E Binda 2002 Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-B dependent up-regulation of IL-8 and MCP-1 Kidney Int 62 846 56
18. A Matussek J Lauber A Bergau W Hansen M Rohde KE Dittmar 2003 Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells Blood 102 1323 32
19. E Nestoridi O Tsukurov RI Kushak JR Ingelfinger EF Grabowski 2005 Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome J Thromb Haemost 3 752 62
20. E Nestoridi RI Kushak D Duguerre EF Grabowski JR Ingelfinger 2005 Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin Kidney Int 67 2254 66
21. SA Ghosh RK Polanowska-Grabowska J Fujii T Obrig AR Gear 2004 Shiga toxin binds to activated platelets J Thromb Haemost 2 499 506
22. C Jenkins GA Willshaw J Evans T Cheasty H Chart DJ Shaw 2003 Subtyping of virulence genes in verocytotoxin-producing Escherichia coli (VTEC) other than serogroup O157 associated with disease in the United Kingdom J Med Microbiol 52 941 7
23. H Nakajima N Kiyokawa YU Katagiri T Taguchi T Suzuki T Sekino 2001 Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance J Biol Chem 276 42915 22
24. M Nangaku CE Alpers J Pippin SJ Shankland S Adler K Kurokawa 1997 A new model of renal microvascular endothelial injury Kidney Int 52 182 94
25. J Shao T Miyata K Yamada N Hanafusa T Wada KL Gordon 2001 Protective role of nitric oxide in a model of thrombotic microangiopathy in rats J Am Soc Nephrol 12 2088 97
26. M Nangaku K Yamada CE Gariepy T Miyata R Inagi K Kurokawa 2002 ET(B) receptor protects the tubulointerstitium in experimental thrombotic microangiopathy Kidney Int 62 922 8
27. M Nangaku CE Alpers J Pippin SJ Shankland K Kurokawa S Adler 1997 Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9 Kidney Int 52 1570 8
28. J Hughes M Nangaku CE Alpers SJ Shankland WG Couser RJ Johnson 2000 C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis Am J Physiol Renal Physiol 278 F747 57
29. M Nangaku 1998 Complement regulatory proteins in glomerular diseases Kidney Int 54 1419 28
30. M Nangaku CE Alpers J Pippin SJ Shankland K Kurokawa S Adler 1998 CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats J Am Soc Nephrol 9 590 7
31. P Warwicker TH Goodship RL Donne Y Pirson A Nicholls RM Ward 1998 Genetic studies into inherited and sporadic hemolytic uremic syndrome Kidney Int 53 836 44
32. J Caprioli P Bettinaglio PF Zipfel B Amadei E Daina S Gamba 2001 The molecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20 J Am Soc Nephrol 12 297 307
33. HP Neumann M Salzmann B Bohnert-Iwan T Mannuelian C Skerka D Lenk 2003 Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries J Med Genet 40 676 81
34. A Richards MR Buddles RL Donne BS Kaplan E Kirk MC Venning 2001 Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition Am J Hum Genet 68 485 90
35. MA Dragon-Durey V Fremeaux-Bacchi C Loirat J Blouin P Niaudet G Deschenes 2004 Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases J Am Soc Nephrol 15 787 95
36. T Manuelian J Hellwage S Meri J Caprioli M Noris S Heinen 2003 Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome J Clin Invest 111 1181 90
37. J Caprioli M Noris S Brioschi G Pianetti F Castelletti P Bettinaglio 2006 International Registry of Recurrent and Familial HUS/TTP. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome Blood 108 1267 79
38. MK Pangburn 2002 Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome J Immunol 169 4702 6
39. M Jozsi S Heinen A Hartmann CW Ostrowicz S Halbich H Richter 2006 Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions J Am Soc Nephrol 17 170 7
40. J Caprioli F Castelletti S Bucchioni P Bettinaglio E Bresin G Pianetti 2003 Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease Hum Mol Genet 12 3385 95
41. M-A Dragon-Durey C Loirat S Cloarec M-A Macher J Blouin H Nivet 2005 Anti-factor H antibodies associated with atypical hemolytic uremic syndrome J Am Soc Nephrol 16 555 63
42. K Hogasen JH Jansen TE Mollnes J Hovdenes M Harboe 1995 Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency J Clin Invest 95 1054 61
43. MC Pickering HT Cook J Warren AE Bygrave J Moss MJ Walport M Botto 2002 Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H Nat Genet 31 424 8
44. C Licht S Heinen M Jozsi I Loschmann RE Saunders SJ Perkins 2006 Deletion of Lys224 in regulatory domain 4 of factor H reveals a novel pathomechanism for dense deposit disease (MPGN II) Kidney Int 70 42 50
45. F Vaziri-Sani L Holmberg AG Sjoholm AC Kristoffersson M Manea V Fremeaux-Bacchi 2006 Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome Kidney Int 69 981 8
46. M Noris S Brioschi J Caprioli M Todeschini E Bresin F Porrati 2003 Familial haemolytic uraemic syndrome and an MCP mutation Lancet 362 1542 7
47. A Richards EJ Kemp MK Liszewski JA Goodship AK Lampe R Decorte 2003 Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome Proc Natl Acad Sci USA 100 12966 71
48. V Fremeaux-Bacchi MA Dragon-Durey J Blouin C Vigneau D Kuypers B Boudailliez 2004 Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome J Med Genet 41 84 8
49. D Kavanagh EJ Kemp E Mayland RJ Winney JS Duffield G Warwick 2005 Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome J Am Soc Nephrol 16 2150 5
50. JC Reynolds LY Agodoa CM Yuan KC Abbott 2003 Thrombotic microangiopathy after renal transplantation in the United States Am J Kidney Dis 42 1058 68
51. A Zarifian S Meleg-Smith R O'Donovan RJ Tesi V Batuman 1999 Cyclosporine-associated thrombotic microangiopathy in renal allografts Kidney Int 55 2457 66
52. P Ruggenenti 2002 Post-transplant hemolytic-uremic syndrome Kidney Int 62 1093 104
53. F Peyvandi SM Siboni D Lambertenghi Deliliers S Lavoretano N De Fazio B Moroni 2006 Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation Br J Haematol 134 187 95
54. H Nishi N Hanafusa Y Kondo M Nangaku Y Sugawara M Makuuchi 2006 Clinical outcome of thrombotic microangiopathy after living-donor liver transplantation treated with plasma exchange therapy Clin J Am Soc Nephrol 1 811 9
55. HM Tsai 2006 The molecular biology of thrombotic microangiopathy Kidney Int 70 16 23
56. HM Tsai 2006 Current concepts in thrombotic thrombocytopenic purpura Annu Rev Med 57 419 36
57. M Furlan R Robles M Galbusera G Remuzzi PA Kyrle B Brenner 1998 von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome N Engl J Med 339 1578 84
58. HM Tsai EC Lian 1998 Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura N Engl J Med 339 1585 94
59. CL Bennett PD Weinberg K Rozenberg-Ben-Dror PR Yarnold HC Kwaan D Green 1998 Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases Ann Intern Med 128 541 4
60. CL Bennett CJ Davidson DW Raisch PD Weinberg RH Bennett MD Feldman 1999 Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention Arch Intern Med 159 2524 8
61. HM Tsai L Rice R Sarode TW Chow JL Moake 2000 Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura Ann Intern Med 132 794 9
62. DG Motto AK Chauhan G Zhu J Homeister CB Lamb KC Desch 2005 Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice J Clin Invest 115 2752 61
63. M Noris G Remuzzi 2005 Hemolytic uremic syndrome J Am Soc Nephrol 16 1035 50
64. K Brunner MG Bianchetti TJ Neuhaus 2004 Recovery of renal function after long-term dialysis in hemolytic uremic syndrome Pediatr Nephrol 19 229 31
65. L De Petris A Gianviti U Giordano A Calzolari AE Tozzi G Rizzoni 2004 Blood pressure in the long-term follow-up of children with hemolytic uremic syndrome Pediatr Nephrol 19 1241 4
66. R Siegler R Oakes 2005 Hemolytic uremic syndrome; pathogenesis, treatment, and outcome Curr Opin Pediatr 17 200 4
67. AX Garg WF Clark M Salvadori J Macnab RS Suri RB Haynes D Matsell 2005 Walkerton Health Study Investigators. Microalbuminuria 3 years after recovery from Escherichia coli O157 hemolytic uremic syndrome due to municipal water contamination Kidney Int 67 1476 82
68. AX Garg WF Clark M Salvadori HR Thiessen-Philbrook D Matsell 2006 Absence of renal sequelae after childhood Escherichia coli O157:H7 gastroenteritis Kidney Int 70 807 12
69. AX Garg RS Suri N Barrowman F Rehman D Matsell MP Rosas-Arellano 2003 Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression JAMA 290 1360 70
70. T Igarashi J Inatomi A Wake M Takamizawa H Katayama T Iwata 1999 Failure of pre-diarrheal antibiotics to prevent hemolytic uremic syndrome in serologically proven Escherichia coli O157:H7 gastrointestinal infection J Pediatr 135 768 9
71. C Wong S Jelacic R Habeeb SL Watkins PI Tarr 2000 The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections N Engl J Med 342 1930 6
72. GZ Panos GI Betsi ME Falagas 2006 Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection? Aliment Pharmacol Ther 24 731 42
73. DP Basile D Donohoe K Roethe JL Osborn 2001 Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function Am J Physiol Renal Physiol 281 F887 99
74. DP Basile DL Donohoe K Roethe DL Mattson 2003 Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage Am J Physiol Renal Physiol 284 F338 48
75. KU Eckardt WM Bernhardt A Weidemann C Warnecke C Rosenberger MS Wiesener C Willam 2005 Role of hypoxia in the pathogenesis of renal disease Kidney Int 99 S46 51
76. LG Fine D Bandyopadhay JT Norman 2000 Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia Kidney Int 75 S22 6
77. DH Kang J Kanellis C Hugo L Truong S Anderson D Kerjaschki 2002 Role of the microvascular endothelium in progressive renal disease J Am Soc Nephrol 13 806 16
78. M Nangaku 2006 Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure J Am Soc Nephrol 17 17 25
79. M Nangaku 2004 Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure Nephron Exp Nephrol 98 e8 12
80. A Schieppati P Ruggenenti RP Cornejo F Ferrario G Gregorini P Zucchelli 1992 Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. The Italian Registry of Haemolytic Uremic Syndrome J Am Soc Nephrol 2 1640 4
81. CM Taylor C Chua AJ Howie RA Risdon 2004 Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome Pediatr Nephrol 19 419 25
82. AR Constantinescu M Bitzan LS Weiss E Christen BS Kaplan A Cnaan H Trachtman 2004 Non-enteropathic hemolytic uremic syndrome: causes and short-term course Am J Kidney Dis 43 976 82
83. G Remuzzi P Ruggenenti D Codazzi M Noris J Caprioli G Locatelli B Gridelli 2002 Combined kidney and liver transplantation for familial haemolytic uraemic syndrome Lancet 359 1671 2
84. G Remuzzi P Ruggenenti B Gridelli A Bertani P Bettinaglio S Bucchioni 2005 Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor H gene mutation Am J Transplant 5 1146 50
85. JM Saland SH Emre BL Shneider C Benchimol S Ames JS Bromberg 2006 Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation Am J Transplant 6 1948 52
86. GA Rock KH Shumak NA Buskard VS Blanchette JG Kelton RC Nair RA Spasoff 1991 Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group N Engl J Med 325 393 7
87. BF Wyllie AX Garg J Macnab GA Rock WF Clark Members of the Canadian Apheresis Group 2006 Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange Br J Haematol 132 204 9
88. MA Howard LA Williams DR Terrell D Duvall SK Vesely JN George 2006 Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Transfusion 46 154 6
89. SL Allford BJ Hunt P Rose S Machin 2003 Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias Br J Haematol 120 556 73
90. JW Smith R Weinstein 2003 Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and American Society for Apheresis Transfusion 43 820 2
91. JN George 2006 Clinical practice. Thrombotic thrombocytopenic purpura N Engl J Med 354 1927 35